{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:25:49Z","timestamp":1779233149013,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.neuroscience.2014.10.050","type":"journal-article","created":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T12:07:12Z","timestamp":1415189232000},"page":"11-23","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Neurotransmitter receptor density changes in Pitx3ak mice \u2013 A model relevant to Parkinson\u2019s disease"],"prefix":"10.1016","volume":"285","author":[{"given":"J.N.","family":"Cremer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Amunts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Graw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Piel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"R\u00f6sch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Zilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2014.10.050_b0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2008.05.013","article-title":"In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson\u2019s Disease","volume":"589","author":"Abin-Carriquiry","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0010","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1387\/ijdb.130193jg","article-title":"Pitx3 directly regulates Foxe3 during early lens development","volume":"57","author":"Ahmad","year":"2013","journal-title":"Int J Dev Biol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0015","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mds.20029","article-title":"Smoking and Parkinson\u2019s disease: systematic review of prospective studies","volume":"19","author":"Allam","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0020","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00335-011-9330-x","article-title":"Parkinson\u2019s disease mouse models in translational research","volume":"22","author":"Antony","year":"2011","journal-title":"Mamm Genome"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0025","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2008.05.017","article-title":"Impaired learning and memory in Pitx3 deficient aphakia mice: a genetic model for striatum-dependent cognitive symptoms in Parkinson\u2019s disease","volume":"31","author":"Ardayfio","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0030","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mds.23895","article-title":"Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease","volume":"27","author":"Ballanger","year":"2012","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0035","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1212\/WNL.0b013e3181c2937c","article-title":"The locus ceruleus norepinephrine system: functional organization and potential clinical significance","volume":"73","author":"Benarroch","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0040","first-page":"80","article-title":"Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson\u2019s disease","volume":"35","author":"Bertrand","year":"1997","journal-title":"Folia Neuropathol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0045","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson\u2019s disease","author":"Blesa","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1353-8020(03)00028-2","article-title":"Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients","volume":"9","author":"Burghaus","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0055","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0006-8993(00)03087-0","article-title":"Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra","volume":"888","author":"Costa","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00429-011-0303-3","article-title":"Laminar distribution of neurotransmitter receptors in different reeler mouse brain regions","volume":"216","author":"Cremer","year":"2011","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0065","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.neuroscience.2009.03.068","article-title":"Pentylenetetrazole-induced seizures affect binding site densities for GABA, glutamate and adenosine receptors in the rat brain","volume":"163","author":"Cremer","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1","article-title":"Depression in patients with Parkinson\u2019s disease","volume":"14","author":"Cummings","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0075","first-page":"427","article-title":"CSF GABA levels in Parkinson\u2019s disease","volume":"40","author":"de Jong","year":"1984","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2007.03.013","article-title":"Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson\u2019s disease","volume":"27","author":"Ding","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0085","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","article-title":"Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration","volume":"38","author":"Doty","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-0270(91)90081-A","article-title":"A new motor test sensitive to aging and dopaminergic function","volume":"39","author":"Drucker-Colin","year":"1991","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0095","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0006-8993(96)00915-8","article-title":"A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome","volume":"741","author":"Gerlach","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1350-9462(98)00018-4","article-title":"Cataract mutations and lens development","volume":"18","author":"Graw","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/(SICI)1520-6408(1998)23:4<299::AID-DVG5>3.0.CO;2-G","article-title":"Aphakia (ak), a mouse mutation affecting early eye development: fine mapping, consideration of candidate genes and altered Pax6 and Six3 gene expression pattern","volume":"23","author":"Grimm","year":"1998","journal-title":"Dev Genet"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0110","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jnnp.62.5.436","article-title":"Olfactory dysfunction in Parkinson\u2019s disease","volume":"62","author":"Hawkes","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.pharmthera.2005.12.001","article-title":"What has been learnt from study of dopamine receptors in Parkinson\u2019s disease?","volume":"111","author":"Hurley","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0169-328X(03)00162-1","article-title":"Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice","volume":"114","author":"Hwang","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0125","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1523\/JNEUROSCI.3718-04.2005","article-title":"3,4-Dihydroxyphenylalanine reverses the motor deficits in Pitx3-deficient aphakia mice: behavioral characterization of a novel genetic model of Parkinson\u2019s disease","volume":"25","author":"Hwang","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0130","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","article-title":"Decrease of nicotinic receptors in the nigrostriatal system in Parkinson\u2019s disease","volume":"29","author":"Kas","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0135","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archneur.60.9.1223","article-title":"Positron emission tomography of striatal serotonin transporters in Parkinson disease","volume":"60","author":"Kerenyi","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0140","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/syn.20722","article-title":"Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats","volume":"64","author":"Li","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0145","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1007\/s00702-009-0274-1","article-title":"Beyond tremor and rigidity: non-motor features of Parkinson\u2019s disease","volume":"116","author":"Lohle","year":"2009","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0150","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/jnc.12160","article-title":"The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress","volume":"125","author":"Luk","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0155","doi-asserted-by":"crossref","first-page":"99S","DOI":"10.1016\/S0893-133X(99)00040-8","article-title":"Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior","volume":"21","author":"Mann","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1749-6632.1990.tb16904.x","article-title":"Role of serotonin in depression","volume":"600","author":"Meltzer","year":"1990","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0170","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0175","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2\u2217-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0180","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of early nonmotor features and risk factors for Parkinson disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0185","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.0230529100","article-title":"Pitx3 is required for development of substantia nigra dopaminergic neurons","volume":"100","author":"Nunes","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00429-005-0024-6","article-title":"Taurine-transporter gene knockout-induced changes in GABAA, kainate and AMPA but not NMDA receptor binding in mouse brain","volume":"210","author":"Oermann","year":"2005","journal-title":"Anat Embryol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0195","first-page":"435","article-title":"A simple quantitative bradykinesia test in MPTP-treated mice","volume":"50","author":"Ogawa","year":"1985","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2007.02.014","article-title":"Quantification of nicotinic acetylcholine receptors in Parkinson\u2019s disease with (123)I-5IA SPECT","volume":"256","author":"Oishi","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0205","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000233254","article-title":"Neurotransmitter receptor imbalances in motor cortex and basal ganglia in hepatic encephalopathy","volume":"24","author":"Palomero-Gallagher","year":"2009","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0210","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cne.10638","article-title":"AMPA, kainate, and NMDA receptor densities in the hippocampus of untreated male rats and females in estrus and diestrus","volume":"459","author":"Palomero-Gallagher","year":"2003","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0215","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1111\/j.1528-1167.2012.03634.x","article-title":"Multireceptor analysis in human neocortex reveals complex alterations of receptor ligand binding in focal epilepsies","volume":"53","author":"Palomero-Gallagher","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s00415-009-5240-1","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"3","author":"Park","year":"2009","journal-title":"J Neurol"},{"issue":"Pt 8","key":"10.1016\/j.neuroscience.2014.10.050_b0225","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1093\/brain\/122.8.1449","article-title":"Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer\u2019s and Parkinson\u2019s diseases: rostrocaudal distribution","volume":"122","author":"Piggott","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson\u2019s disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0235","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1111\/j.1471-4159.2006.04078.x","article-title":"Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates","volume":"98","author":"Quik","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.mehy.2010.07.024","article-title":"Bupropion as the treatment of choice in depression associated with Parkinson\u2019s disease and it\u2019s various treatments","volume":"75","author":"Raskin","year":"2010","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0245","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1006\/geno.2000.6464","article-title":"A double-deletion mutation in the Pitx3 gene causes arrested lens development in aphakia mice","volume":"72","author":"Rieger","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0255","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/jnr.490270409","article-title":"PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson\u2019s disease","volume":"27","author":"Rinne","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/mds.870050114","article-title":"Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson\u2019s disease","volume":"5","author":"Rinne","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0265","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/archneur.64.7.990","article-title":"Pooled analysis of tobacco use and risk of Parkinson disease","volume":"64","author":"Ritz","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0270","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1002\/ana.410440726","article-title":"Subthalamic nucleus-mediated excitotoxicity in Parkinson\u2019s disease: a target for neuroprotection","volume":"44","author":"Rodriguez","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.neuroscience.2012.08.004","article-title":"Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice","volume":"223","author":"Rojas","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0280","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.21291","article-title":"Association of olfactory dysfunction with risk for future Parkinson\u2019s disease","volume":"63","author":"Ross","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0285","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0006-8993(83)90993-9","article-title":"Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson\u2019s disease","volume":"275","author":"Scatton","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0290","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/hmg\/9.11.1575","article-title":"Deletion in the promoter region and altered expression of Pitx3 homeobox gene in aphakia mice","volume":"9","author":"Semina","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0295","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/syn.20734","article-title":"Striatal and extrastriatal dopamine release measured with PET and [18F]fallypride","volume":"64","author":"Slifstein","year":"2010","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0300","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1242\/dev.01022","article-title":"Early developmental failure of substantia nigra dopamine neurons in mice lacking the homeodomain gene Pitx3","volume":"131","author":"Smidt","year":"2004","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0305","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4088\/PCC.v06n0403","article-title":"A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor","volume":"6","author":"Stahl","year":"2004","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0310","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1016\/j.bmc.2007.07.017","article-title":"In vitro affinities of various halogenated benzamide derivatives as potential radioligands for non-invasive quantification of D2-like dopamine receptors","volume":"15","author":"Stark","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0315","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02260911","article-title":"Monoamine metabolism in the cerebrospinal fluid in Parkinson\u2019s disease: relationship to clinical symptoms and subsequent therapeutic outcomes","volume":"5","author":"Tohgi","year":"1993","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0320","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2005.03522.x","article-title":"Striatal neuroadaptation and rescue of locomotor deficit by L-DOPA in aphakia mice, a model of Parkinson\u2019s disease","volume":"96","author":"van den Munckhof","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0325","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1242\/dev.00464","article-title":"Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons","volume":"130","author":"van den Munckhof","year":"2003","journal-title":"Development"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0330","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1096\/fj.09-141044","article-title":"A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson\u2019s disease","volume":"24","author":"Varani","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0335","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0340","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","article-title":"Non-motor dysfunction in Parkinson\u2019s disease","volume":"13","author":"Ziemssen","year":"2007","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0355","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0306-4522(99)00392-9","article-title":"Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography","volume":"94","author":"Zilles","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/1098-1063(2000)10:3<213::AID-HIPO2>3.0.CO;2-Q","article-title":"Water maze and radial maze learning and the density of binding sites of glutamate, GABA, and serotonin receptors in the hippocampus of inbred mouse strains","volume":"10","author":"Zilles","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0360","series-title":"Brain mapping: the methods","first-page":"573","article-title":"Quantitative analysis of cyto- and receptor architecture of the human brain","author":"Zilles","year":"2002"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0345","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0924-977X(02)00108-6","article-title":"Architectonics of the human cerebral cortex and transmitter receptor fingerprints: reconciling functional neuroanatomy and neurochemistry","volume":"12","author":"Zilles","year":"2002","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2014.10.050_b0350","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.0021-8782.2004.00357.x","article-title":"Transmitter receptors and functional anatomy of the cerebral cortex","volume":"205","author":"Zilles","year":"2004","journal-title":"J Anat"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214009221?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452214009221?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T20:52:40Z","timestamp":1538081560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452214009221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":73,"alternative-id":["S0306452214009221"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2014.10.050","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}